Analyst Ratings for Axsome Therapeutics (AXSM)
AXSM Rating Summary
AXSM Price Target Summary
- Highest: $260.00 (H.C. Wainwright)
- Lowest: $150.00 (Leerink Partners)
- Average: $211.24
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$211.24 (+30.1%)
* Over Last 12-Mos
Rating Score: 9.6 / 10
Percentile Rank: 91%
Avg. $ Target:
$211.24 (+30.1%)
* Over Last 12-Mos
Rating Score: 9.6 / 10
Percentile Rank: 91%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/24/2026 | Wolfe Research | Rudy Li | New Coverage | Outperform (N/A) |
230.00 (N/A) |
183.72 (162.33) |
-11.64% | Details |
| 1/8/2026 | Morgan Stanley » Updated 2/24/2026 |
Sean Laaman | Downgrade | Equalweight (Overweight) |
207.00 (204.00) |
171.88 (162.33) |
-5.56% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
